Thyroid Hormone Deficiency – Risk Factors, Symptoms, and Treatment Options

Contemporary endocrinology continues to conduct advanced research into the multifaceted mechanisms underlying the development of hypothyroidism, clinically referred to as an underactive thyroid. Among the predominant etiologic factors—one that has gained increasing epidemiological significance in recent decades—is chronic autoimmune thyroiditis, commonly known as Hashimoto’s thyroiditis. This condition is characterized by a pathological immune response in which T lymphocytes and autoantibodies target the thyroid’s own structural components, leading to progressive destruction of glandular parenchyma and, ultimately, functional insufficiency. Beyond autoimmune triggers, iatrogenic thyroid damage also plays a critical role, particularly following surgical interventions such as total thyroidectomy or radioiodine therapy administered for hyperthyroidism or malignant neoplasms. Furthermore, the impact of dietary deficiencies, particularly chronic iodine insufficiency, cannot be overlooked, as iodine remains an essential trace element for thyroid hormone synthesis. Clinical observations additionally reveal a clear correlation between patient age and the rising incidence of hypothyroidism, suggesting an association with physiological aging processes and the cumulative exposure to risk factors.

This condition is notably insidious in its progression, as its manifestations are frequently overlooked or dismissed as mere consequences of fatigue or stress. Individuals with insufficient thyroid hormone production commonly report persistent physical and mental exhaustion, excessive daytime somnolence, slowed cognitive and motor responses, and depressive mood disturbances. Frequent complaints also include chronic constipation, severe xerosis of the skin, brittle and delaminating nail plates, and pronounced alopecia. A particularly troubling symptom is the propensity for weight gain despite adherence to a calorie-restricted diet. In advanced cases, periorbital edema, cervical enlargement due to goiter formation, hoarseness, or a lowered vocal pitch may develop. Severe hormonal deficiency can lead to pathological fluid redistribution within the body, manifesting as ascites, peripheral edema (facial, upper and lower extremity swelling), and effusions in the pleural and pericardial cavities.

Prior to attempting conception, it is critically important for a woman to undergo a thorough endocrine evaluation, with particular emphasis on thyroid function parameters. Uncontrolled thyroid hormone deficiencies can lead to severe complications, including congenital developmental anomalies in the fetus as well as numerous abnormalities throughout the course of pregnancy. Furthermore, these disorders frequently coincide with menstrual irregularities, which may further complicate the process of achieving pregnancy. In the absence of appropriate hormonal treatment, there is an elevated risk of spontaneous miscarriage, preterm labor, and placental abruption—each of which poses a direct threat to fetal survival. Additionally, pregnant women with unmanaged hypothyroidism may develop pathological conditions such as preeclampsia, characterized by a sudden increase in blood pressure and proteinuria. This condition carries significant risks for both maternal health and the proper intrauterine development of the child, necessitating immediate medical intervention.

In the evaluation of thyroid dysfunction, the measurement of thyroid-stimulating hormone (TSH)—a glycoprotein synthesized by the anterior pituitary gland—represents the cornerstone and most routinely performed diagnostic test. Its principal role involves modulating thyroid activity by promoting the biosynthesis of two critical hormones: triiodothyronine (T3) and thyroxine (T4). Through a negative feedback mechanism, diminished levels of free T3 and T4 trigger an compensatory elevation in TSH secretion, a hallmark of primary hypothyroidism. Conversely, suppressed TSH concentrations may indicate secondary hypothyroidism stemming from hypothalamic-pituitary axis dysfunction. During the initial phases of the disease, an isolated TSH elevation may occur while peripheral hormone levels remain within reference ranges (subclinical hypothyroidism). The established reference interval for TSH spans 0.27–4.2 µIU/ml. For differential diagnosis—particularly in cases of suspected autoimmune etiology (Hashimoto’s thyroiditis)—quantification of anti-thyroid peroxidase antibodies (anti-TPO) is indispensable. Concurrent metabolic derangements in hypothyroidism often include elevated liver enzyme markers (transaminases) and hypercholesterolemia. Complementary imaging via thyroid ultrasonography facilitates assessment of echotexture, glandular volume, and potential focal lesions within the organ.

The cornerstone of hypothyroidism management is synthetic levothyroxine (L-thyroxine), a pharmaceutical agent designed to restore euthyroid status by normalizing thyroid-stimulating hormone (TSH) levels. Administration is optimally timed for the morning, strictly on an empty stomach, with a mandatory 30-minute interval preceding breakfast to ensure unimpeded absorption. Dosage titration is highly individualized, guided by comprehensive laboratory assessments of TSH, triiodothyronine (T3), and thyroxine (T4) concentrations. Initial dose adjustments typically occur after a 4–6 week interval from therapy commencement, at which point follow-up blood tests—conducted fasting and *without* prior medication intake—are performed to evaluate hormonal response dynamics. Consistent monitoring of these biomarkers remains indispensable for long-term therapeutic efficacy. Beyond pharmacological intervention, nutritional optimization plays a pivotal role in managing hypothyroidism. A meticulously balanced diet must provide adequate intake of critical micronutrients—including iodine (in moderation), selenium, zinc, and B vitamins—whose deficiencies may exacerbate metabolic dysfunctions. In cases of autoimmune etiology (e.g., Hashimoto’s thyroiditis), a tailored elimination diet, preceded by food intolerance testing, is often warranted. Particular attention should be directed toward minimizing exposure to goitrogenic compounds such as thiocyanates and glucosinolates, which are prevalent in cruciferous vegetables (e.g., Brussels sprouts, kale, cauliflower); thermal processing (e.g., steaming or boiling) partially mitigates their antithyroid effects. As a systemic disorder, hypothyroidism necessitates an integrated treatment approach that synergizes pharmacotherapy with dietary modifications and lifestyle adaptations, thereby alleviating symptoms and enhancing patients’ overall well-being. Scientific reference: Tuchendler P., Zdrojewicz Z., *Nutritional Interventions in Thyroid Disorders*, „Family Medicine“ 2017;20(4):299–303 (original publication in Polish).